These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29699789)

  • 1. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
    Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VaxArray assessment of influenza split vaccine potency and stability.
    Kuck LR; Saye S; Loob S; Roth-Eichhorn S; Byrne-Nash R; Rowlen KL
    Vaccine; 2017 Apr; 35(15):1918-1925. PubMed ID: 28262335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
    Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
    Couch RB; Atmar RL; Keitel WA; Quarles JM; Wells J; Arden N; Niño D
    Vaccine; 2012 Dec; 31(1):190-5. PubMed ID: 23107591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
    Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
    Johansson BE
    Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.
    Hassantoufighi A; Zhang H; Sandbulte M; Gao J; Manischewitz J; King L; Golding H; Straight TM; Eichelberger MC
    Vaccine; 2010 Jan; 28(3):790-7. PubMed ID: 19887135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
    Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
    Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
    Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
    Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
    Petrie JG; Ohmit SE; Johnson E; Truscon R; Monto AS
    J Infect Dis; 2015 Dec; 212(12):1914-22. PubMed ID: 26014800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    Saluja V; Visser MR; Ter Veer W; van Roosmalen ML; Leenhouts K; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2010 Nov; 28(50):7963-9. PubMed ID: 20946860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.